EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C15H16N2O3 |
| Net Charge | 0 |
| Average Mass | 272.304 |
| Monoisotopic Mass | 272.11609 |
| SMILES | C/C=C1\C[C@H]2C=Nc3c(ccc(OC)c3O)C(=O)N2C1 |
| InChI | InChI=1S/C15H16N2O3/c1-3-9-6-10-7-16-13-11(15(19)17(10)8-9)4-5-12(20-2)14(13)18/h3-5,7,10,18H,6,8H2,1-2H3/b9-3+/t10-/m0/s1 |
| InChIKey | FOMJEHKAWAOFOV-RZCNENHTSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Micrococcus (ncbitaxon:1269) | - | PubMed (19388705) |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| Limazepine E (CHEBI:217072) is a benzodiazepine (CHEBI:22720) |
| IUPAC Name |
|---|
| (6aS,8E)-8-ethylidene-4-hydroxy-3-methoxy-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-11-one |
| Manual Xrefs | Databases |
|---|---|
| 24617023 | ChemSpider |